Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer.
Kluth M, Volta H, Hussein M, Taskin B, Frogh S, Möller-Koop C, Büscheck F, Jacobsen F, Tsourlakis MC, Lübke AM, Hinsch A, Clauditz T, Graefen M, Heinzer H, Huland H, Minner S, Sauter G, Wilczak W, Schlomm T, Simon R.
Kluth M, et al. Among authors: lubke am.
Cancer Manag Res. 2018 Nov 19;10:5909-5917. doi: 10.2147/CMAR.S172637. eCollection 2018.
Cancer Manag Res. 2018.
PMID: 30510458
Free PMC article.